Business Context and Reporting Period
This Form 8-K was filed by Uranium Energy Corp. (UEC) on June 13, 2022. The report details the entry into a Material Definitive Agreement to acquire UEX Corporation (UEX) via a statutory plan of arrangement under the Canada Business Corporations Act.
Key Financial Metrics and Transaction Terms
- Exchange Ratio: UEX shareholders will receive 0.0831 UEC shares for each UEX share.
- Consideration Value: Approximately C$0.43 per UEX share.
- Premium: Approximately 50% over the UEX closing price on the Toronto Stock Exchange (TSX) as of June 10, 2022.
- Post-Closing Ownership: Existing UEC shareholders will own approximately 86.3%, and UEX shareholders will own approximately 13.7% of the combined entity.
- Termination Fee: UEX agreed to pay UEC US$8.25 million if the agreement is terminated under specified circumstances.
- Private Placement Funding: UEC agreed to provide C$5 million in funding to UEX via a private placement of UEX shares at C$0.43 per share, subject to TSX approval.
Material Changes and Transaction Status
The primary material change is the execution of the Arrangement Agreement. The transaction is expected to close in the third calendar quarter of 2022. Completion is contingent upon several conditions, including:
- Approval by at least 66 2/3% of votes cast by UEX shareholders.
- Approval by a simple majority of UEX shareholders, excluding certain management votes, per Canadian Securities Administrators rules.
- Receipt of court and stock exchange approvals.
- Investment Canada approval.
UEX intends to hold a shareholder meeting in August 2022 to seek approval. The UEX Board of Directors has unanimously approved the arrangement, and directors/officers holding approximately 0.5% of shares have entered into voting support agreements.
Guidance, Outlook, and Risks
Management Commentary and Opinions: TD Securities and Sprott Capital Partners provided opinions to the UEX Board stating the consideration is fair from a financial point of view. The agreement includes non-solicitation covenants with "fiduciary out" provisions allowing UEX to consider superior proposals, subject to a right to match period for UEC.
Risks and Contingencies: The transaction is subject to regulatory approvals (including Investment Canada) and shareholder votes. Failure to meet these conditions could result in termination and the payment of the termination fee.
Financial Metrics: The filing text does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for either company. This report focuses solely on the transaction structure.
Investor Verification Checklist
- Verify the outcome of the UEX shareholder meeting scheduled for August 2022.
- Monitor the status of regulatory approvals, specifically from Investment Canada and the TSX.
- Confirm the closing date remains within the third quarter of 2022.
- Review the full Arrangement Agreement (Exhibit 10.1) for detailed termination conditions and covenants.